Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma

British Journal of Cancer

Volumn 93, Issue 1, 2005, Pages 159-166

  Brennan, P ^a   Scelo G ^a   Hemminki, K ^b,c   Mellemkjaer, L ^d   Tracey, E ^e   Andersen, A ^f   Brewster, D H ^g   Pukkala, E ^h   McBride, M L ⁱ   Kliewer, E V ^j,k   Tonita, J V ^l   Seow, A ^m   Pompe Kirn, V ⁿ   Martos, C ^o   Jonasson, J G ^p,q   Colin, D ^a   Boffetta, P ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e New South Wales Cancer Registry   (Australia)

^f INSTITUTE OF CANCER RESEARCH   (Norway)

^g INFORMATION SERVICES DIVISION   (United Kingdom)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^j CANCERCARE MANITOBA   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

^l SASKATCHEWAN CANCER AGENCY   (Canada)

^m Centre for Molecular Epidemiology   (Singapore)

ⁿ INSTITUTE OF ONCOLOGY   (Slovenia)

^o Cancer Registry of Zaragoza   (Spain)

^p ICELANDIC CANCER REGISTRY   (Iceland)

^q UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

Cancer registries; Non Hodgkin's lymphoma; Second primary cancers

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CHILD; COLON CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INFANT; KIDNEY CANCER; LIP CANCER; LIVER CANCER; LUNG CANCER; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA; NOSE CAVITY CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMALL INTESTINE CANCER; SOFT TISSUE CANCER; STOMACH CANCER; THYROID CANCER; TONGUE CANCER;

AGED; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY;

EID: 23144457283     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602654     Document Type: Article

References (29)

1. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M (1995) Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 310: 1491-1495
2. Boice Jr JD, Storm HH, Curtis RE, Jensen OM, Kleinerman RA, Jensen HS, Flannery JT, Fraumeni Jr JF (1985) Introduction to the study of multiple primary cancers. In National Cancer Institute Monograph No 68 - Multiple Primary Cancers in Connecticut and Denmark NCI (ed) pp 3-9. NIH Publication: Bethesda
3. Bray I, Brennan P, Boffetta P (2001) Recent trends and future projections of lymphoid neoplasms - a Bayesian age-period-cohort analysis. Cancer Causes Control 12: 813-820
4. Brennan P, Coates M, Armstrong B, Colin D, Boffetta P (2000) Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 82: 1344-1347, doi: 10.1054/bjoc.l999.1102
5. Cartwright R, McNally R, Staines A (1994) The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 14: 387-394
6. Dong C, Hemminki K (2001) Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 85: 997-1005, doi: 10.1054/bjoc.2001.1998
7. Geoffroy-Perez B, Janin N, Ossian K, Lauge A, Croquette MF, Griscelli C, Debre M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93: 288-293
8. Hanlon FR (1931) Multiple primary carcinomas. Am J Cancer 15: 2001
9. Hemminki K, Jiang Y, Steineck G (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function? Eur J Cancer 39: 223-229
10. Herrinton LJ, Friedman GD (1998) Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 7: 25-28
11. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112: 865-871, doi: 10.1002/ijc.20470
12. IARC Monographs on the evaluation of carcinogenic risks to humans Suppl 7 (1987) Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Vol 1-42. IARC: Lyon
13. IARC Monographs on the evaluation of carcinogenic risks to humans Vol 64 (1995) Human Papillomaviruses. IARC: Lyon
14. IARC Monographs on the evaluation of carcinogenic risks to humans Vol 75 (2000) Ionizing Radiation, Part 1: X- and Gamma (γ)-Radiation, and Neutrons. IARC: Lyon
15. Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Saracci R (1997) Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol 145: 1061-1075
16. McKenna DB, Stockton D, Brewster DH, Doherty VR (2003) Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 88: 74-78, doi: 10.1038/sj.bjc.6600692
17. McMichael AJ, Giles GG (1996) Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 73: 945-950
18. Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, Flynn S, Tallini G, Zhang B, Owens PH, Zheng T (2003) Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer 89: 2087-2092, doi: 10.1038/sj.bjc.6601388
19. Muir CS, Percy C (1991) Classification and coding for neoplasms. In IARC Scientific Publication No. 95: Cancer Registration - Principles and Methods Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) pp 64-81. IARC: Lyon
20. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (2004) B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 111: 1-8, doi: 10.1002/ijc.20205
21. Newton R, Ferlay J, Beral V, Devesa SS (1997) The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer 72: 923-930
22. Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR (2000) Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 37: 341-349
23. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (1992) Cancer in Five Continents Vol VI. IARC: Lyon
24. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer in Five Continents Vol VIII. IARC: Lyon
25. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, Sundstrom C, Glimelius B, Adami HO (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97: 199-209
26. Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S, Senoiri CA, Vigano C, Vindigni C, Vineis P (2004) Non-Hodgkin's lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 13: 431-437
27. Storm HH, Prener A (1985) Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80. In National Cancer Institute Monograph No. 68 - Multiple Primary Cancers in Connecticut and Denmark NCI (ed) pp 389-409. NIH Publication: Bethesda
28. Travis LB, Curtis RE, Boice Jr JD, Hankey BF, Fraumeni Jr JF (1991) Second cancers following non-Hodgkin's lymphoma. Cancer 67: 2002-2009
29. Travis LB, Gonzalez CL, Hankey BF, Jaffe ES (1992) Hodgkin's disease following non-Hodgkin's lymphoma. Cancer 69: 2337-2342